DAFNA Capital Management LLC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 114 filers reported holding ATHIRA PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q1 2022$2,173,000
+3.6%
160,9830.0%0.57%
+7.2%
Q4 2021$2,098,000
+38.9%
160,9830.0%0.53%
+31.7%
Q3 2021$1,510,000
-8.4%
160,9830.0%0.40%
+16.2%
Q2 2021$1,648,000
-2.1%
160,983
+75.9%
0.34%
-13.8%
Q1 2021$1,684,000
+197.5%
91,531
+453.7%
0.40%
+138.1%
Q4 2020$566,00016,5310.17%
Other shareholders
ATHIRA PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,704,362$3,442,8113.16%
Simplify Asset Management Inc. 1,492,792$3,015,4400.34%
Perceptive Advisors 4,797,278$9,690,5010.32%
Nan Fung Group Holdings Ltd 180,000$363,6000.29%
Potomac Capital Management, Inc. 74,585$150,6620.19%
Acuitas Investments, LLC 149,600$302,1920.18%
TANG CAPITAL MANAGEMENT LLC 352,715$712,4840.10%
GSA CAPITAL PARTNERS LLP 297,052$6000.05%
Integrity Financial Corp /WA 32,786$66,2280.05%
Laird Norton Wetherby Trust Company, LLC 178,709$360,9920.05%
View complete list of ATHIRA PHARMA INC shareholders